Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Tango Therapeutics, Inc. (TNGX) vs Xenon Pharmaceuticals Inc. (XENE)

Tango Therapeutics, Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Tango Therapeutics, Inc. is the larger, with a market value of $4.2B against $3.7B — 1.1× the size. Tango Therapeutics, Inc. grew revenue faster over the last twelve months: 48.3% against −8.15%. Across the 14 metrics below, Tango Therapeutics, Inc. leads on 10 and Xenon Pharmaceuticals Inc. on 4.

Valuation

Metric TNGX XENE Biotechnology median
P/E n/m n/m 7.88
P/S 59.87 217.29 11.47
P/B 3.65 2.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 43.62 162.98 10.73
Earnings yield (3.37%) (12.83%) (28.84%)
Free cash flow yield (3.86%) (9.20%) (23.03%)

Profitability

Metric TNGX XENE Biotechnology median
Gross margin 100.00% 28.40% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (21.34%) (43.62%) (57.72%)
Return on assets (18.86%) (41.54%) (49.22%)
Return on invested capital (808.35%) (88.54%) 0.00%

Growth

Metric TNGX XENE Biotechnology median
Revenue growth (TTM) 48.29% (8.15%) 5.64%
EPS growth (last fiscal year) 26.89% (44.85%) —
Revenue growth, 5-year CAGR 52.13% 89.00% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric TNGX XENE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 50.82 21.02 4.73
Net debt to EBITDA 3.08 1.48 0.96

Dividend

Metric TNGX XENE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric TNGX XENE Biotechnology median
Market cap 4.15b 3.73b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack